Cargando…
The clinical course of bone metastases from breast cancer.
All patients with carcinoma of the breast seen in this Unit since 1970 were reviewed to study the incidence, prognosis, morbidity and response to treatment of bone metastases. The biological characteristics of the primary tumour were compared in patients relapsing first in bone or liver. Sixty-nine...
Autores principales: | Coleman, R. E., Rubens, R. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001575/ https://www.ncbi.nlm.nih.gov/pubmed/3814476 |
Ejemplares similares
-
Clinical course and prognostic factors following bone recurrence from breast cancer.
por: Coleman, R. E., et al.
Publicado: (1998) -
Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
por: Coleman, R. E., et al.
Publicado: (1988) -
Biochemical prediction of response of bone metastases to treatment.
por: Coleman, R. E., et al.
Publicado: (1988) -
Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry.
por: Twelves, C. J., et al.
Publicado: (1989) -
Markers of bone turnover for the management of patients with bone metastases from prostate cancer
por: Garnero, P, et al.
Publicado: (2000)